Skip to main content

Focused Wealth Management, Inc

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1586052 Newburgh, NY

Position in REGN

as of Mar 31, 2026 · filed Apr 20, 2026
Position Value
$296,693
+$188,895 QoQ
Shares Held
384
+242.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Derivatives in REGN

reported options exposure · as of Mar 31, 2024
CallValue
$384,996
CallShares
400
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Focused Wealth Management, Inc holds $2,056,911 across 2 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in REGN

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $296,693 384
2024-03-31 $384,996 400
2024-03-31 $107,798 112
2023-12-31 $9,661 11
2023-09-30 $21,396 26
2023-06-30 $49,579 69
2023-03-31 $56,695 69
2022-12-31 $49,782 69
2022-09-30 $47,532 69
2022-06-30 $40,787 69
2022-03-31 $37,714 54
2021-12-31 $34,102 54
2021-09-30 $32,679 54
2021-06-30 $30,161 54
2021-03-31 $25,549 54
2020-12-31 $26,087 54
2020-09-30 $5,038 9
2020-06-30 $99,160 159
2020-03-31 $4,394 9